GVR Report cover Defibrillator Market Size, Share & Trends Report

Defibrillator Market Size, Share & Trends Analysis Report By Product (ICDs, External Defibrillators), By End Use (Hospital, Pre Hospital, Public Access Market, Alternate Care Market, Home Healthcare), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-368-3
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2021
  • Industry: Healthcare

Report Overview

The global defibrillators market size was valued at USD 12.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.20% from 2023 to 2030. Increasing product developments, rising incidence of sudden cardiac arrest, growing awareness among the general public, and supportive initiatives by governments and healthcare organizations are some of the key factors fueling the growth of this market. In May 2021, an Australian company- Rapid Response Revival Research Ltd. received a CE mark for its CellAED-the world’s first personal AED for home use. This supported the company’s growth strategy.

North America defibrillators market size and growth rate, 2023 - 2030 (USD Billion)

The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Death due to sudden cardiac arrest is attributable to nearly half of all deaths from cardiovascular diseases despite developments in prevention and treatment. This is anticipated to drive innovation in the market while increasing demand for both ICDs and external defibrillators. Ami Italia, for instance, manufactures a range of defibrillators as part of its Saver One series, Geo Saver series, and Smarty Saver series. The Smarty Series, for example, can be used by anyone in medical and nonmedical fields in various settings, such as ambulances, emergency rooms, and public or private places. Microport, on the other hand, is the leader in the cardiac rhythm management market in China. It registered 95% growth in revenue during H1 2021 in the Chinese market owing to a wide portfolio and robust product pipeline.


COVID-19 defibrillators market impact: 7.20% decline in demand

Pandemic Impact

Post COVID Outlook

The defibrillators market experienced a negative growth rate of 7.20% from 2019 to 2020, due to the postponement of cardiovascular procedures categorized as elective surgeries

The market is expected to gain pace in 2021, by reaching USD 11.8 billion at a year-on-year growth of 8.15%

Key market participants such as Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., and Defibtech, LLC, experienced negative growth in 2020

Market players are expected to focus on investing in rapid defibrillation devices for home healthcare purposes. The segment of AEDs is also expected to experience growth in the coming years

Boston Scientific Corporation registered a decline of 12.12% in its cardiac rhythm management segment, which consists of defibrillators amongst other cardiovascular devices



Growing awareness regarding cardiovascular events in developing markets is another key driver for the market. In the UAE, the number and usage of defibrillators are notably low. However, the presence of local distributors and increasing initiatives to raise awareness regarding cardiac health are expected to contribute to the market growth in the coming years. In September 2019, the Dubai Corporation for Ambulance Services (DCAS) announced that it would donate 80 AEDs to various places of worship, private and government entities, and other venues in the city, in addition to training chosen volunteers. This was part of the My City Saves Me campaign to create and connect a pool of trained volunteers through DCAS’ Help Me app. Some of the leading distributors active in the UAE include Defibrillator Dubai, Gulf AED, AED Dubai, and Atlas Medical Group.

End-use Insights

Hospitals held the largest revenue share of over 80.0% in 2022. This is owing to the higher number of cardiac patients received in hospitals and surgeries performed in hospital settings. Both ICDs and external defibrillators are increasingly used in hospitals to deliver treatment to patients of sudden cardiac arrest and for other indications. Boston Scientific, for example, reported a distribution of around 659,000 ICDs globally as of January 2021. This number notably increased by 59,000 when compared to the 600,000 ICDs distributed by January 2020 indicating a high demand.

The public access market segment is anticipated to register the fastest growth rate of about 10% over the forecast period due to the rising initiatives to increase the availability of public access AEDs, train personnel, and improve response to sudden cardiac arrest events. In January 2020, Global Times reported that several tourist cities, first-tier cities, and coastal provinces across China have initiated accelerated AED deployment since 2019. Hangzhou also became the first city in China to mandate the dissemination of AEDs at airports, metro stations, law enforcement vehicles, ships, and other public places.

Product Insights

Implantable cardioverter defibrillators (ICDs) dominated the market by product in 2022. The key factors driving this segment include the growing adoption of these devices due to the high prevalence of cardiovascular diseases, the high geriatric population in key markets, and growing product improvements by major companies. Medtronic, for instance, reported continued acceptance and expansion of its MRI-compatible Claria CRT-D devices in 2020. This was in addition to strong growth recorded for its Crome & Cobalt portfolio of CRT-Ds and ICDs.

Global defibrillators market share and size, 2022 (%) 

The external defibrillators segment is anticipated to register the fastest growth rate of 9.0% over the forecast period. This is due to technological advancements and initiatives promoting access to AEDs in public places. A bill to enhance availability and access to AEDs (Public Access) in the U.K. is in the pipeline. If the bill is cleared, it will become mandatory to install defibrillators at public places, thus boosting the demand for AEDs. Favorable regulatory policies and initiatives by public and private health organizations to promote public access to defibrillators already exist in several key markets, including the U.S., Canada, Italy, Japan, Australia, and China.

Regional Insights

North America held the largest revenue share of more than 35.0% in 2022. The growth of the North American market can be attributed to the initiatives by key players, favorable regulations, and technologically advanced healthcare facilities in the U.S. and Canada. Boston Scientific, for instance, reported that it had distributed about 33,000 of its CRT-Ds line-up including Resonate, Autogen, Dynagen, Incepta, and Cognis devices worldwide in 2020. Out of these, 16,500 were registered in the U.S. alone indicating a high adoption rate.

Defibrillator Market Trends by Region, 2023-2030

Asia Pacific is projected to expand at the fastest CAGR of 8.1% over the forecast period. This is owing to developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases. The regional growth is spearheaded by the Japanese market owing to the high penetration of defibrillators and supportive policies. In fact, Nihon Kohden, a market leader in Japan registered over USD 66,000 sales of manual external defibrillators in 2020.

Key Companies & Market Share Insights

The market has been characterized by intense competition. Market players incorporate various strategic initiatives to increase their market share. These include product development, regional expansion, partnerships and collaborations, and mergers & acquisitions. For instance, in August 2019, ZOLL Medical Corporation acquired Cardiac Science Corporation- a leading AEDs manufacturer in the U.S. This strengthened ZOLL's AED product portfolio and accelerated the global expansion plans of the company’s AED business. In February 2020, Abbott, on the other hand, received CE Mark for its Gallant ICDs and CRT-D devices. This supported the company’s growth objectives. Some prominent players in the global defibrillator market include:  

  • Medtronic

  • Abbott

  • Boston Scientific Corporation


  • MicroPort Scientific Corporation

  • Koninklijke Philips N.V.

  • Stryker

  • ZOLL Medical Corporation (Asahi Kasei)

  • Nihon Kohden Corporation

  • Progetti Srl

  • Schiller AG

  • MS Westfalia GmbH

  • AMI Italia

  • AXION Ltd.

  • Bexen Cardio

  • MicroPort Scientific Corporation

  • Asahi Kasei Corporation

  • CU Medical Systems

  • METsis Medikal

  • Mediana Co. Ltd.

  • Mindray Medical International Ltd.

  • Progetti SRL – Medical Equipment Solutions

  • BPL Medical Technologies

  • Metrax GmbH – PRIMEDIC

  • Element Science Inc.

  • Avive Solutions Inc.

  • Jeevtronics Pvt. Ltd.

  • HeartHero Inc.

  • Shenzhen Comen Medical Instruments Ltd.

Defibrillator Market Report Scope

Report Attribute


Market size value in 2023

USD 12.8 billion

Revenue forecast in 2030

USD 20.8 billion

Growth rate

CAGR of 7.20% from 2023 to 2030

Base year for estimation


Historical data

2017 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million/billion & CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, end-use, region

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Denmark; Sweden; Norway; Thailand; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Medtronic; Abbott; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Koninklijke Philips N.V.; Stryker; ZOLL Medical Corporation (Asahi Kasei); Nihon Kohden Corporation; Progetti Srl; Schiller AG; MS Westfalia GmbH; AMI Italia; AXION Ltd0.; Bexen Cardio; MicroPort Scientific Corporation; Asahi Kasei Corporationz; CU Medical Systems; METsis Medikal; Mediana Co. Ltd.; Mindray Medical International Ltd.; Progetti SRL – Medical Equipment Solutions; BPL Medical Technologies; Metrax GmbH – PRIMEDIC; MS Westfalia GmbH; Bexen Cardio; Axion Medical Equipment Ltd.; Element Science Inc.; Avive Solutions Inc.; Jeevtronics Pvt. Ltd.; HeartHero Inc.; Shenzhen Comen Medical Instruments Ltd.

Customization scope

Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this report, Grand View Research has segmented the global defibrillators market report on the basis of product, end use, and region:

Global Defibrillator Market Segmentation

  • Product Outlook (Revenue, USD Million, 2017 - 2030)

    • Implantable Cardioverter Defibrillators (ICD)

      • S-ICD

      • T-ICD

        • Single Chamber

        • Dual Chamber

        • CRT-D

    • External Defibrillators (ED)

      • Manual ED

      • Automated ED

      • Wearable Cardioverter Defibrillators

  • End-use Outlook (Revenue, USD Million, 2017 - 2030)

    • Hospital

    • Pre Hospital

    • Public Access Market

    • Alternate Care Market

    • Home Healthcare

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon